Alahist CF (Poly Pharmaceuticals, Inc.)


Welcome to the PulseAid listing for the Alahist CF drug offered from Poly Pharmaceuticals, Inc.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Poly Pharmaceuticals, Inc.
NON-PROPRIETARY NAME: dexbrompheniramine maleate, dextromethorphan Hbr, Phenylephrine Hcl
SUBSTANCE NAME: DEXBROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: OTC MONOGRAPH FINAL
START MARKETING DATE: 2017-09-14
END MARKETING DATE: 0000-00-00


Alahist CF HUMAN OTC DRUG Details:

Item DescriptionAlahist CF from Poly Pharmaceuticals, Inc.
LABELER NAME: Poly Pharmaceuticals, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 2; 20; 10(g/1; g/1; g/1)
START MARKETING DATE: 2017-09-14
END MARKETING DATE: 0000-00-00
PRODUCT ID: 50991-784_59774c8a-deb0-53a6-e053-2991aa0a709f
PRODUCT NDC: 50991-784
APPLICATION NUMBER: part341

Other DEXBROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Advanced Generic CorporationBionatuss
Kramer NovisSUPRESS A
Poly Pharmaceuticals, Inc.Alahist CF
Seyer Pharmatec, Inc.Panatuss